Open main menu
Search Ctrl + K
Free Trial
Loading...
Aadi Bioscience, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.AADI
17383 Sunset Avenue, Suite A250, Pacific Palisades, CA, 90272
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Latest Filings – Ownership
144
Lennon David James
03 Oct 24
4
Lennon David James
03 Oct 24
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
01 Oct 24
4
Desai Neil
05 Sep 24
SC 13G
03 Sep 24
144
Desai Neil
03 Sep 24
SC 13G
28 Aug 24
4
Desai Neil
05 Aug 24
4
Desai Neil
02 Jul 24
4
Hehenberger Karin M.
14 Jun 24
4
Dalal Anupam
14 Jun 24
4
Reeve Emma
14 Jun 24
4
Aghazadeh Behzad
14 Jun 24
4
Castelein Caley
14 Jun 24
4
Hirmand Mohammad
14 Jun 24
4
Maroun Richard E
14 Jun 24
4
Desai Neil
05 Jun 24
144
Desai Neil
03 Jun 24
4
Desai Neil
01 May 24
3
Ball Bryan
26 Apr 24
Latest Filings – Non-Ownership
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
06 Nov 24
10-Q
Quarterly Filing
06 Nov 24
8-K
Other Events
30 Sep 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
19 Sep 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
22 Aug 24
8-K
Cost Associated With Exit Or Disposal Activities, Other Events, Financial Statements And Exhibits
21 Aug 24
10-Q
Quarterly Filing
07 Aug 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
07 Aug 24
8-K
Submission Of Matters To A Vote Of Security Holders
12 Jun 24
10-Q
Quarterly Filing
08 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 May 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
03 May 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
30 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
26 Apr 24
ARS
Scanned Paper Annual Report Submission.
26 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
26 Apr 24
8-K
Entry Into A Material Definitive Agreement
04 Apr 24
10-K
Fiscal Year 2024
13 Mar 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
13 Mar 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
12 Feb 24